Role of Multi-Targeted Tyrosine Kinase Inhibitors in RAI-Refractory Differentiated Thyroid Cancer

被引：0
|
作者：
Haddad, Robert
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2014年 / 12卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 18
页数：6
相关论文
共 50 条
  • [1] IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer
    Crezee, Thomas
    Tesselaar, Marika H.
    Jaeger, Martin
    Rabold, Katrin
    Corver, Willem
    Morreau, Hans
    Van Engen-Van Grunsven, Adriana C. H.
    Smit, Jan W. A.
    Netea-Maier, Romana T.
    Plantinga, Theo S.
    [J]. ONCOLOGY LETTERS, 2021, 22 (02)
  • [2] Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer
    Gianoukakis, Andrew G.
    Choe, Jennifer H.
    Bowles, Daniel W.
    Brose, Marcia S.
    Wirth, Lori J.
    Owonikoko, Taofeek
    Babajanyan, Svetlana
    Worden, Francis P.
    [J]. EUROPEAN THYROID JOURNAL, 2024, 13 (01)
  • [3] Tyrosine kinase inhibitors: Multi-targeted or single-targeted?
    Broekman, Fleur
    Giovannetti, Elisa
    Peters, Godefridus J.
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (02): : 80 - 93
  • [4] Tyrosine Kinase Inhibitors for Radioactive Iodine Refractory Differentiated Thyroid Cancer
    Cortas, Christos
    Charalambous, Haris
    [J]. LIFE-BASEL, 2024, 14 (01):
  • [5] MULTI-TARGETED TYROSINE KINASE INHIBITORS PLUS CHEMOTHERAPY
    Ivy, S. P.
    Chen, H.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 25 - 25
  • [6] Advanced RAI-refractory thyroid cancer: an update on treatment perspectives
    Karapanou, Olga
    Simeakis, George
    Vlassopoulou, Barbara
    Alevizaki, Maria
    Saltiki, Katerina
    [J]. ENDOCRINE-RELATED CANCER, 2022, 29 (05) : R57 - R66
  • [7] Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders
    Sever, Belgin
    Saso, Luciano
    Tzoneva, Rumiana
    Onnis, Valentina
    Ciftci, Halilibrahim
    [J]. FRONTIERS IN CHEMISTRY, 2024, 12
  • [8] Potential role of multi-targeted inhibitors in non-small-cell lung tyrosine kinase cancer
    Scagliotti, G. V.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 32 - 41
  • [9] Redifferentiation Therapy for RAI-Refractory Differentiated Thyroid Cancers Based on Tumor Genomic Assay
    Shen, D.
    Chan, H.
    Tsai, F.
    Chiu, Y.
    Liang, T.
    She, Y.
    Li, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S173 - S174
  • [10] Multi-targeted tyrosine kinase inhibitors and VEGFR-targeting agents
    Eckhardt, SG
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 20 - 20
12345